# An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

> **NCT01485952** · PHASE1 · COMPLETED · sponsor: **Siena Biotech S.p.A.** · enrollment: 55 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **DRUG:** SEN0014196 (Low Dose)
- **DRUG:** SEN0014196 (High Dose)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01485952
- **Lead sponsor:** Siena Biotech S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2015-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485952, "An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01485952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*